Metabolic dysfunction‐associated steatotic liver disease and BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant: correspondence

Ähnliche Einträge

• Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant
  von: Lok Ka Lam, et al.
  Veröffentlicht: (2024)
• Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
  von: Kazuma Mori, et al.
  Veröffentlicht: (2024)
• Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility
  von: Connor Henry‐Blake, et al.
  Veröffentlicht: (2024)
• Association of metabolic dysfunction‐associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study
  von: Masahiro Sogabe, et al.
  Veröffentlicht: (2024)
• Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
  von: Yi‐Ting Chen, et al.
  Veröffentlicht: (2024)